Literature DB >> 4547148

Australia antigen and cell-mediated immunity.

V Reisenbuk, S Ioks.   

Abstract

Mesh:

Substances:

Year:  1974        PMID: 4547148     DOI: 10.1007/bf01240552

Source DB:  PubMed          Journal:  Arch Gesamte Virusforsch        ISSN: 0003-9012


× No keyword cloud information.
  9 in total

1.  LYMPHOCYTE INTERACTION: A POTENTIAL HISTOCOMPATIBILITY TEST IN VITRO.

Authors:  F BACH; K HIRSCHHORN
Journal:  Science       Date:  1964-02-21       Impact factor: 47.728

2.  Poliovirus inhibition of the phytohemagglutinin response in human lymphocytes.

Authors:  F T Willems; W E Rawls
Journal:  Arch Gesamte Virusforsch       Date:  1969

3.  Lymphocyte transformation by Australia antigen.

Authors:  A A Laiwah
Journal:  Lancet       Date:  1971-08-28       Impact factor: 79.321

4.  Viral hepatitis. New light on an old disease.

Authors:  S Krugman; J P Giles
Journal:  JAMA       Date:  1970-05-11       Impact factor: 56.272

5.  Lymphocyte transformation by phytohemagglutinin: IV. In acute upper respiratory infections.

Authors:  J W Thomas; D Clements; S C Naiman
Journal:  Can Med Assoc J       Date:  1968-09-14       Impact factor: 8.262

6.  Lymphocyte transformation and hepatitis. I. Impairment of thymidine incorporation and DNA polymerase activity.

Authors:  S S Agarwal; B S Blumberg; B J Gerstley; W T London; I Millman; A I Sutnick; L A Loeb
Journal:  Proc Soc Exp Biol Med       Date:  1971-09

7.  Leukocyte mitosis: suppression in vitro associated with acute infectious hepatitis.

Authors:  B Mella; D J Lang
Journal:  Science       Date:  1967-01-06       Impact factor: 47.728

8.  Replication of poliovirus in phytohemagglutinin-stimulated human lymphocytes.

Authors:  F T Willems; J L Melnick; W E Rawls
Journal:  J Virol       Date:  1969-05       Impact factor: 5.103

9.  Abnormalities of in vitro lymphocyte responses during rubella virus infections.

Authors:  G B Olson; P B Dent; W E Rawls; M A South; J R Montgomery; J L Melnick; R A Good
Journal:  J Exp Med       Date:  1968-07-01       Impact factor: 14.307

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.